Search

1 to 10 of 172
Sort by

Event
34th Annual Meeting & Pre-Conference Programs (SITC 2019)

The 34 th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019) scheduled to take place Nov. 6-10, 2019, at the Gaylord National Hotel & Convention Center in National Harbor, Md. Click here to download a PDF flyer about SITC 2019. Dates to...

 11-06-2019 08:00 - 11-10-2019 12:00 ET
 National Harbor MD


Web Page
Meet-the-Expert Webinars

The Society for Immunotherapy of Cancer (SITC) is excited to announce a new series of free webinars dedicated solely for early career scientists. The SITC Meet-the-Expert Webinars, kicking off on Thursday, Jan. 17, will accommodate young investigators seeking to engage with luminaries in the...


Web Page
Immune-related Adverse Events

SUmmary Current Guideline Subcommittee The SITC Cancer Immunotherapy Guidelines Immune-related Adverse Events Subcommittee will soon convene to develop a consensus statement specific to immune-related adverse events. Current Guideline New Guideline in Progress Cancer Immunotherapy...


Web Page
Lymphoma

SUmmary Current Guideline Subcommittee The SITC Cancer Immunotherapy Guidelines Lymphoma Subcommittee will soon convene to develop a consensus statement specific to lymphoma. Current Guideline New Guideline in Progress Cancer Immunotherapy Guidelines Lymphoma Subcommittee...


Web Page
Multiple Myeloma

SUmmary Current Guideline Subcommittee The SITC Cancer Immunotherapy Guidelines Multiple Myeloma Subcommittee will soon convene to develop a consensus statement specific to multiple myeloma. Current Guideline New Guideline in Progress Cancer Immunotherapy Guidelines Multiple Myeloma...


Web Page
Cancer Immunotherapy Winter School

Attend the Cancer Immunotherapy Winter School New Comprehensive Cancer Immunotherapy Program Provides Advanced Training Join the Society for Immunotherapy of Cancer (SITC) for this comprehensive cancer immunotherapy program, in Mesa, Ariz., Feb. 18–22, 2019. Taught by leading experts, this five...


Library Entry
Isolation of T cell receptors targeting recurrent neoantigens in hematological malignancies

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article authors aimed to identify MHC class I neoepitopes derived from mCALR and isolate TCRs against such neoepitopes with the potential to be utilized clinically for TCR gene therapy. Authors: Vanessa M. Tubb, ...


Web Page
SITC Meeting Code of Conduct

Anti-Harassment/Personal Safety and Security Approved by the SITC Executive Committee, June 2018 The Society for Immunotherapy of Cancer (SITC) is committed to provide a safe, secure, collegial and welcoming environment for all participants and attendees at its meetings and events, and to...


Web Page
Boston, Mass. - 9/27

Thursday, Sept. 27 4:30 - 9 p.m. EDT Organizers: Elizabeth Buchbinder, MD – Dana-Farber Cancer Institute David F. McDermott, MD – Beth Israel Deaconess Medical Center Virginia Seery, MSN, RN, ANP-BC – Beth Israel Deaconess Medical Center ACI-Boston Program Registration This program has...


Web Page
ASCO 2018 Meeting Highlights

The Society for Immunotherapy of Cancer (SITC) is pleased to present highlights of the latest advances in immunotherapy emerging from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago on June 1–5, 2018. This page will be updated as daily recaps are published....